Results 51 to 60 of about 2,572,587 (193)

Management and efficacy of intensified insulin therapy starting in outpatients [PDF]

, 1989
Diabetic patients under multiple injection insulin therapy (i.e., intensified insulin therapy, IIT) usually start this treatment during hospitalization. We report here on the logistics, efficacy, and safety of IIT, started in outpatients.
Winkelmann, W., W. Hummerich, M. Steffen, B. Allolio, Allolio, B., G. Ollenschläger, W. Winkelmann, M. Reincke, Hummerich, W., Steffen, M., Ollenschläger, G., Reincke, Martin   +11 more
core   +1 more source

Successful management of allergy to the insulin excipient metacresol in a child with type 1 diabetes: a case report

Journal of Medical Case Reports, 2012
Introduction Insulin allergy to human insulin preparations during the treatment of diabetes is suggested to occur at rates ranging from
Wheeler Benjamin J, Taylor Barry J
doaj   +1 more source

Continuous subcutaneous insulin infusion in patients with type 1 disease

, 2017
Optimal blood glucose control and the restoration of physiological insulin secretion is an ongoing medical challenge. Continuous subcutaneous insulin infusion (CSII) aims to restore blood glucose levels and reduce the frequency of hypoglycaemic events ...
Tughreed Fatani, Wong, L, Fatani, T, Louise Wong, Meetoo, D, Danny Meetoo   +5 more
core   +1 more source

The effect of DAFNE education, continuous subcutaneous insulin infusion, or both in a population with type 1 diabetes in Scotland [PDF]

, 2019
Aim: To investigate the effect of DAFNEand continuous subcutaneous insulin infusion in clinical practice. Methods: Within NHS Lothian, continuous subcutaneous insulin infusion started in 2004 and DAFNE education began in 2006.
Cunningham, S G, Colhoun, H.M., Ochs, A, McKnight, O, Gibb, F., Colhoun, H. M., Gibb, F, Mair, C, S. J. McGurnaghan, McKnight, J. A., Strachan, M, Strachan, M., Cunningham, S.G., McGurnaghan, S J; id_orcid, Mair, C., Ochs, A., McGurnaghan, S.J., Cunningham, S. G.; id_orcid, S. Ritchie, McKnight, J.A., H. M. Colhoun, McGurnaghan, S. J., M. Strachan, McKnight, O., Wright, R., A. Ochs, Wright, R, J. A. McKnight, C. Mair, O. McKnight, Ritchie, S, F. W. Gibb, S. G. Cunningham, Ritchie, S., Colhoun, H M, McKnight, J A, R. Wright   +36 more
core   +1 more source

Provision of continuous subcutaneous insulin infusion to type 1 diabetes 'frequent flyers'

, 2023
A few people with type 1 diabetes undergo multiple hospital admissions for acute glycaemic events. We report on a series of five such 'frequent flyers' who were provided with continuous subcutaneous insulin infusion (CSII) therapy.
Amato, L. A., Yu, W., Kalolo, R., Simmons, David (R18068)   +3 more
core   +1 more source

Continuous intraperitoneal insulin infusion as a valuable approach in patients with unstable type 1 diabetes: two case reports and a mini review of the literature

Frontiers in Medicine
In recent years, continuous intraperitoneal insulin infusion (CIPII) has become a valid therapeutic option to achieve good glycemic control for patients with unstable type 1 diabetes and subcutaneous insulin resistance, mainly due to the absorption of ...
Erika Pedone, Amelia Caretto, Giulio Belfiori, Anna Zanardini, Sergio Di Molfetta, Luigi Laviola, Francesco Giorgino, Lorenzo Piemonti, Lorenzo Piemonti, Lorenzo Piemonti, Marina Scavini, Andrea Laurenzi, Andrea Laurenzi   +12 more
doaj   +1 more source

Successful management of severe diabetic ketoacidosis in a patient with type 2 diabetes with insulin allergy: a case report

BMC Endocrine Disorders, 2019
Background Diabetic ketoacidosis (DKA) is an acute, major, life-threatening complication of diabetes that requires immediate treatment. Allergic reaction to insulin is rare, especially when using recombinant human insulin.
Anh Dat Nguyen, Chinh Quoc Luong, Hieu Chi Chu, Van Khoa Dieu Nguyen, Chi Van Nguyen, Tuan Anh Nguyen, Quan Huu Nguyen, Ton Duy Mai, Dinh Van Nguyen, Bay Quang Nguyen, Thong Huu Tran, Phuong Viet Dao, Dat Tuan Nguyen, Nguyet Nhu Nguyen, Son Ngoc Do   +14 more
doaj   +1 more source

Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas

, 1991
To compare the effects of continuous subcutaneous insulin infusion (CSII) and conventional insulin therapy (CIT) in patients with poorly controlled sulfonylurea-treated diabetes ...
Lewis, K S, Ward, J D, Talbot, J F, Jennings, A M, Murdoch, S, Bradley, Clare   +5 more
core  

Online_Appendix – Supplemental material for Impact of Medicare Continuous Subcutaneous Insulin Infusion Policies in Patients With Type 1 Diabetes

, 2019
Supplemental material, Online_Appendix for Impact of Medicare Continuous Subcutaneous Insulin Infusion Policies in Patients With Type 1 Diabetes by Nicholas B. Argento, Jingwen Liu, Allyson S. Hughes and Alicia H. McAuliffe-Fogarty in Journal of Diabetes
Nicholas B. Argento (6540473), Allyson S. Hughes (6540476), Alicia H. McAuliffe-Fogarty (6540479), Jingwen Liu (517390)   +3 more
core   +1 more source

Supporting patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Difficulties, disconnections, and disarray [PDF]

, 2017
Rationale, aims, and objectives: Use of continuous subcutaneous insulin infusion therapy in type 1 diabetes management is high. However, the incorporation of this technology into self-care is not without challenges, and the support of an appropriately ...
Steven James, Julia Lowe, James, Steven, Steinbeck, K, Robyn Gallagher, James, S, Perry, L, Janet Dunbabin, Dunbabin, J, Lowe, J, Katharine Steinbeck, Lin Perry, Gallagher, R   +12 more
core   +1 more source